[1]
“Determination of a vector of therapy for weakness in incurable breast cancer patients based on the level of inflammatory response”, Вопр. онкол., vol. 62, no. 1, pp. 104–111, Dec. 2016, doi: 10.37469/0507-3758-2016-62-1-104-111.